Microtek Medical Holdings, Inc - Current report filing
27 October 2007 - 7:03AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE
COMMISSION
Washington
, D.C.
20549
CURRENT
REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported):
October 23, 2007
_______________________
MICROTEK
MEDICAL HOLDINGS, INC.
(Exact
name of registrant as specified in its charter)
Georgia
|
0-24866
|
58-1746149
|
(State
or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
13000
Deerfield Parkway, Suite
300
, Alpharetta, Georgia
30004
(Address
of principal executive office) (zip
code)
Registrant's
telephone number, including area
code:
(678) 896-4400
__________________________________________________
(Former
name or former address, if changed since last
report)
_________________________
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the
following provisions (see General Instruction A.2. below):
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act
(17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act
(17 CFR 240.13e-4(c))
Item
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year
On
October 23, 2007, the Board of Directors of Microtek Medical Holdings, Inc.
(the
“Company”) acted to amend the Company’s Amended and Restated Bylaws for purposes
of allowing book-entry ownership of the Company’s shares. The Amended and
Restated Bylaws, as so amended, are contained in Exhibit 3.1 attached to
this
report and incorporated herein by reference.
Item 9.01 Financial Statements
and Exhibits.
(a) Financial statements
of businesses
acquired.
N/A
(b) Pro forma financial
information.
N/A
(c) Shell company transactions.
N/A
(d) Exhibits.
Exhibit
Number
|
Description
|
3.1
|
Amended
and Restated Bylaws of Microtek Medical Holdings, Inc.
|
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Company
has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
MICROTEK MEDICAL
HOLDINGS, INC.
|
|
|
Date:
October 25, 2007
|
By:
/s/ Dan R. Lee
|
|
Dan
R. Lee, Chairman, President and Chief Executive
Officer
|
|
|
EXHIBIT
INDEX
Exhibit
Number
|
Description
|
3.1
|
Amended
and Restated Bylaws of Microtek Medical Holdings, Inc.
|
Microtek Medical (NASDAQ:MTMD)
Historical Stock Chart
From May 2024 to Jun 2024
Microtek Medical (NASDAQ:MTMD)
Historical Stock Chart
From Jun 2023 to Jun 2024